Bernhardt Zeiher - Mar 14, 2024 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Stock symbol
AMLX
Transactions as of
Mar 14, 2024
Transactions value $
$0
Form type
3
Date filed
3/15/2024, 04:31 PM
Previous filing
Apr 4, 2023
Next filing
Jun 7, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney